Matthew T Campbell

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Matthew T Campbell
Jan 21, 2025, 15:32 | Science
Mohammad Jad Moussa: What drives post-surgical relapse in SCNEC of the Urinary Tract
Mohammad Jad Moussa, Oncology Fellow at MD Anderson Cancer Center, posted on X about recent…
Jan 14, 2025, 07:59 | Science
Vadim Koshkin: Genomic Biomarkers Associated with EV Outcomes for Patients with Advanced Urothelial Carcinoma
Vadim Koshkin, Associate Professor of Clinical Medicine UC San Francisco, shared a recent article by…
Dec 24, 2024, 14:29 | Drugs
Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X: “Advanced urothelial carcinoma…
Dec 23, 2024, 13:06 | Blog
Omar Alhalabi: Analysis of UNITE Study Data
Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared on X: “Hot-off-press. Genomic…
Dec 22, 2024, 11:44 | Insight
Mohammad Jad Moussa: Combining ICIs with Antiangiogenic Agents in Advanced Urothelial Cancer
Mohammad Jad Moussa, Oncology Fellow at MD Anderson Cancer Center, shared a post on X:…
Dec 19, 2024, 14:08 | Blog
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared on X: "Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer…
Nov 30, 2024, 23:26 | Blog
Enrique Grande: SITC Guideline on Immunotherapy for Urothelial Cancer
Enrique Grande, the Head of Oncology at MD Anderson Cancer Center Madrid, shared a post…
Nov 9, 2024, 10:58 | Blog
Pavlos Msaouel: Methodological challenges and solutions in estimating os from Randomized Controlled Trials
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a…
Oct 7, 2024, 07:05 | Insight
Andrew W Hahn: How effective and tolerable is Belzutifan in treating Sporadic Metastatic Clear Cell Renal Cell Carcinoma
Andrew W Hahn, Genitourinary Medical Oncologist, MD Anderson Cancer Center, shared a post on X:…
Sep 20, 2024, 16:11 | Insight
Stefan Maksimović: Our first paper about TKIs and ccRCC in bone and lung!
Stefan Maksimović shared a post by Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at…
Aug 19, 2024, 12:16 | Insight
Talal El Zarif: After adjuvant immunotherapy, what comes next in renal cell carcinoma?
Talal El Zarif shared a post by Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber…
Aug 16, 2024, 14:16 | Insight
Karl Semaan: First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma
Karl Semaan, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “Just…
Jul 19, 2024, 14:41 | Blog
DOR to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared a post on X: ''Durable Objective Response to Lurbinectedin in Small Cell…
Apr 11, 2024, 14:28 | Insight
New Paper Alert! Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors
Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors  Authors: Matthew T Campbell,…
All: 14 Posts: 1 - 100
Special Coverage